Wilshire Advisors LLC
- SEC CIK
- 0001616628
- Latest filing
- Jul 27, 2026
FATE holding history
Fate Therapeutics Inc in every 13F filed by Wilshire Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FATE overviewAll 13F holders of FATEFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −8,486,822−100.0% | Sold out | Holders |
| Q3 2025 | 8,486,822 | $10.7M | 27.7% | +8,486,822 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −4,083−100.0% | Sold out | Holders |
| Q1 2025 | 4,083 | $13.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 4,083 | $7.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 4,083 | $15.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 4,083 | $13.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 4,083 | $30.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 4,083 | $15.3K | <0.1% | +4,083 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −4,083−100.0% | Sold out | Holders |
| Q2 2022 | 4,083 | $101.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 4,083 | $158.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 4,083 | $239.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 4,083 | $242.0K | 0.6% | +4,083 | New | Holders |